Back to Journal

SM Ophthalmology Journal

Significance of Primary Posterior Capsulotomy using Nd:Yaglaser in Pediatric Cataract Surgery

[ ISSN : 3068-0743 ]

Abstract Citation Introduction Materials and Methods Results Discussion Conclusion References
Details

Received: 22-Oct-2018

Accepted: 02-Nov-2018

Published: 08-Nov-2018

Sajeev Cherian Jacob, Antony CL, Indu Govind and Venkataramana Kalikivayi* 

Department of Ophthalmology, Ahalia Foundation Eye Hospital, India

Corresponding Author:

Venkataramana Kalikivayi, Head of the Department, Ahalia School of Optometry, Ahalia Foundation Eye Hospital, Palakkad, Kerala, India, Tel: +91 9380764631; Email: kalikivayi@yahoo.com

Keywords

Developmental Cataract; Capsulotomy; Nd:YAGlaser; Capsulorhexis; Anterior Vitrectomy

Abstract

Background/Purpose: To evaluate the effectiveness of primary neodymium-doped yttrium aluminum garnet (Nd:YAG) laser posterior capsulotomy in pediatric cataract surgeries.

Methods: Retrospective analyses of 19 eyes of 11 patients with developmental cataract who had undergone cataract surgery between 2012 to 2016 were included in the study. All the cases that had undergone phacoemulsification with foldable acrylic Intra Ocular Lens (IOL) in which the posterior capsule was left intact, and followed by Nd:YAG capsulotomy after one to two weeks’ of surgery were included. Traumatic cataracts and those which needed anterior vitrectomy due to dehiscence of posterior capsule were excluded from the study.

Results: The mean age of the study population was 7.42 ± 3.39 years withaminimum age of 3 years andamaximum of 14 years. The maximum follow-up period was found to be 33 months. The mean preoperative visual acuity in the study group was 0.87 log MAR units anda statistically significant improvement was noted post operatively. All 19 eyes had a clear visual axis at thelast follow up. No eye developed visual axis opacification or required any further intervention.

Conclusion: This study proposes that leaving the vitreous undisturbed and performing YAG capsulotomy after two weeks is moreeffective than a primary posterior capsulorhexis with anterior vitrectomy especially in children older than 3 years. It is a safe and easier method even at the hands of inexperienced surgeons who may have to take up a developmental cataract in under developed and less accessible parts of the world.

Citation

Jacob SC, Antony CL, Govind I and Kalikivayi V. Significance of Primary Posterior Capsulotomy using Nd:Yaglaser in Pediatric Cataract Surgery. SM Opthalmol J. 2018; 4(1): 1015

Introduction

Pediatric cataract is an important and preventable cause of blindness. Congenital cataracts are responsible for about 5 to 20% of blindness in children worldwide. The overall prevalence of childhood cataract and congenital cataract ranges from 0.32 to 22.9 per 10000 children and 0.63 to 9.74 per 10000 respectively. The incidence ranges from 1.8 to 3.6 per 10000 per year [1]. Pediatric cataracts are classified into congenital, developmental and traumatic. Congenital cataracts present with in the first year of life whereas developmental cataracts present after infancy. The management of pediatric cataract varies in each case depending on the morphology, density, location and the laterality of the cataract and is not only dependent on the age at presentation.

Surgical treatment is not indicated in all pediatric cataracts. If the opacities are punctate with clear cortex in between andallowmaintaining a reasonably good vision, the surgical management can be delayed. The child can be prescribedmydriatics if required and has to be followed up carefully, monitoring the visual acuity as well as the progression of the cataract [2,3]. Cataracts which are dense enough or which are in the central visual axis can interfere with the proper development of the sensory visual pathway in children. Hence these type of cataracts have to be managed early. Extraction of unilateral cataracts is advised within 4-6 weeks and bilateral cataracts within 6-8weeks of life to prevent amblyopia and strabismus [4,5]. Stimulus deprivation amblyopia may be irreversible if not treated sufficiently early. The critical steps in themanagement of pediatric cataract that determines the visual outcomeare anearly diagnosis, adequate surgical procedure,and aggressive amblyopia therapy.

Pediatric cataract surgeries differ from adults and are more challenging as they have a thinner and less rigid sclera and a very elastic lens capsule. Moreover, there are increased chances of developing severe inflammatory response after surgery in young age [6,7]. Superior scleral incisions are preferred commonly by most surgeons. Anterior capsulotomy techniques include a continuous curvilinear capsulorhexis manually or vitrectorhexis or radiofrequency diathermy. Lens removal can be done by manual irrigation and aspiration (as these cataracts are very soft) or using phacoemulsification. The management of posterior capsule after cataract extraction is important as posterior capsular opacification in later stages lead to amblyopia. Posterior capsulorhexis with anterior vitrectomy is being considered as the gold standard in the management of pediatric cataract [8]. Leaving the posterior capsule intact has been found to be associated with high rates of posterior capsular opacification [8]. Many surgeons,however, do not perform anterior vitrectomy for older children [9]. Long term complications like cystoid macular edema are more likely after vitrectomy [10]. The chances of formation of inflammatory membrane and vitritis are also high following disturbance of vitreous [11]. In 1994, Atkinson and Hiles [12] had reported leaving the posterior capsule intact and performing neodymium-doped yttrium aluminum garnet (Nd:YAG) lasercapsulotomy under a second general anesthesia in the early postoperative period. They had used H.S. Meridian Microruptor III Nd:YAGlaser which is mounted vertically to be used in supine position in operating theatre. These instruments are rarely manufactured and used today.

In this work, the post-operative complications and visual axis opacification in children older than three years were evaluated. These subjects were in whom a primary posterior capsulorhexis and anterior vitrectomy during surgery was avoided and aNd:YAG capsulotomy between one to two weeks after surgery was performed when the eye was quite

Materials and Methods

The study comprised retrospective evaluation of 19 eyes of 11 patients with developmental cataract who had undergone cataract surgery from 2010 to 2016. Institutional Review Board (IRB) approvalwas obtained before starting the study. Ten out of the 11 patients had bilateral cataract of which 2 patients had already underwent surgery in one eye elsewhere. Mean age of the children was 7.42 ±3.39 years. Complete ocular examination was performed in all the cases. All surgeries were done by a single surgeon. All the patients underwent surgery under general anesthesia. Scleral tunnel incision was done in all cases and anterior capsulotomy was done using cystotomecanulaor rhexis forceps. The lens material was aspirated with simcoecanula or irrigation aspiration mode of phacoemulsificator. AcrySof IQ posterior chamber Intra Ocular Lens (IOL) was used in all except one case in which Matrix Acrylic three piece IOL was used. This patient had a history of trauma. Hence the surgeon felt a possibility of PC rupture during surgery and a 3 piece IOL was chosen. Posterior capsulorhexis and vitrectomy werenot done in any case. All eyes were treated with antibiotics and steroids topically for 6 weeks in a tapering dose and cyclopentolate for 2 weeks. A low potent steroid loteprednol was used topically to prevent occurrence of steroid induced glaucoma and systemic steroids were used as per body weight as an anti-inflammatory.

Nd:YAGlaser capsulotomy was performed for all eyes in a period between one to two weeks following surgery. As the post-operative inflammatory response is minimal during this period and the PC will be thin and a minimal energy is sufficient for a capsulotomy, the surgeon felt this to be an appropriate period. A complete slit lamp examination, fundus examination with 90 D and indirect ophthalmoscopy was done prior to the procedure. Intra Ocular Pressure (IOP) was always checked prior to the procedure. The need and nature of the procedure was explained to the parents and informed consent wasobtained. YAG capsulotomy was performed under topical anaesthesia with xylocaine jelly in cooperativepatients and syrup Triclofos was used in children less than 5 years who were not cooperative. The duration of the procedure was between 2 - 5 minutes.The pupil was dilated before procedure and an Abraham lens was used. The average YAG laser intensity needed was 2 mj per pulse. As stated by Arbisser [13] the size of the capsulotomy opening was always made larger than the size of the optics of the IOL. Hanging fragments were avoided by making a regular uniform opening because they can remain and cause visual interference. One drop of brimonidine was instilled immediately after the procedure. The average rise in IOP was found to be 5mm Hg. IOP was again measured after 4 hours and was always found to be with in normal range. After the capsulotomy,all patients were reviewed thenext day and after one week.

Results

The study group consisted of 19 eyes of 11 patients of which 12 were males and 7 were females. Mean age of the study population was 7.42 ± 3.39 years with minimum age of 3 years and maximum of 14 years. Mean age of males and females were 8.42 ± 3.6 years and 5.71 ± 2.3 years respectively. The target refraction for children < 2 years, 2-5 years and > 5 years were fixed at 20%, 15-20%, and 10-15% of under correction respectively. The mean axial length of the study group was 23.06 ± 1.33 mm with minimum of 19.3 mm and maximum of 24.48 mm. The mean IOL power was 20.28 ± 4.97D with minimum of 12D and maximum of 28.5D. The contact A-scan method was performed in cooperative children and on table immersion ultrasound A-scan method was performed for children who are not cooperative.Hoffer Q formula was used to calculate IOL power for the axial lengths < 22 mm and SRK/T formula was used for the axial lengths of 22-24.5mm. T he IOL power implanted was adjusted for age according to standard protocol. All the patients were followed up at 1 week and 1 month. Few patients were lost to follow up after one month. The mean follow up period for remaining patients after 1 month was at 8.54, 19.42, 26.6 and 37.58 months for the third, fourth, fifth and sixth follow up respectively. The maximum follow up period was found to be 42 months. The details of follow up visits along with the number of eyes are given in Table 1.

Table 1: Showing number of eyes followed up in each visit.

FOLLOW UP

NUMBER OF EYES

1st visit

19

2nd visit

19

3rd visit

14

4th visit

7

5th visit

4

6th visit

2

The mean preoperative visual acuity in the study group was 0.87 log MAR units. The mean visual acuity at each follow up visit is calculated (Table 2).

Table 2: Showing mean visual acuity in log MAR at each follow up

VISIT

VA in Log MAR

PREOP

0.87

1st visit

0.38

2nd visit

0.31

3rd visit

0.21

4th visit

0.29

5th visit

0.19

6th visit

0.21

The follow up visits are further divided into 3 time periods of 0-9, 10-19 and 20-26 months. At each visit, a statistically significant improvement in the Log MAR visual acuity post operatively was noted with a p value of less than 0.05 and is shown in Figure 1.

Figure 1: Mean Log MAR acuity at different follow up periods.

Refraction was done for all patients at 1 month review. The mean spherical equivalent was found to be + 0.50 ± 1.24 D with a minimum of -0.75 D and maximum of +2.6 D. The mean cylinder was found to be 1.225 ± 0.78 DC with a range of -2.00 D to zero. The mean postoperative visual acuity for the children < 5 years and > 5 years of age was found to be 0.16 and 0.20 Log MAR units and was found to be statistically insignificant with p > 0.05.

All 19 eyes had a clear visual axis at last follow up. No eye developed posterior capsular opacification or required any further procedure. None of the eyes had any complications like posterior synechiae formation, glaucoma, cystoid macular edema or retinal detachment. There was zero percentage incidence of visual axis opacification in the study group.

Discussion

There are different methods for management of posterior capsule in a pediatric cataract. Posterior capsulorhexis with anterior vitrectomy has been considered as the best option. Primary posterior capsulorhexis during cataract surgery is usually done manually or using diathermy or vitrectomy probe followed by anterior vitrectomy. Posterior Continuous Curvilinear Capsulorhexis (PCCC) is a difficult procedure to perform for most surgeons and requires much expertise. First step to perform a manual PCCC is filling the capsular bag with viscoelastic. Using cystitome posterior capsule is ripped from center towards periphery and completed with utrata forceps by frequent grasping and regrasping. The diameter of PCCC is usually kept less than that of anterior capsulorhexis. Vitreous face disruption is the main complication while doing a PCCC. Vitreous disturbance is recognized by pupil or rhexis margin deformation or by visible strands of vitreous. Howard V. Gimbel and Abhay R. Vasavada [13] stated preserving the anterior vitreous face without a vitrectomy helps in avoiding future retinal complications in children. Hence anNd:YAG capsulotomy after one to two weeks’ time instead of a PCCC was opted.

The incidence of Posterior Capsular Opacification (PCO) when the posterior capsule is left intact is reported between 42 to 100 percent in various studies [14,15]. Studies [16-18] have also been done where posterior capsulorhexis was done without anterior vitrectomy and were found to be safe and effective in older children. In addition to age, material of IOL used has also shown to affect the occurrence of PCO. Hydrophobic acrylic lenses are found to reduce the rate of PCO [19].

The risk of post-operative complications is higher in paediatric age group due to greater inflammatory response after surgery [7,20]. Paediatric cataract surgery is associated with a higher incidence of uveal inflammatory reaction. Petric et al. [21] noted higher incidence of uveal inflammatory reaction in the group with posterior capsule opacification and vitrectomy, which was attributed to the age of the patients. Postoperative complications, such as inflammatory response, may contribute to visual axis obstruction. Vasavada et al. [22] reported posterior synechia formation in 34.6% of eyes where posterior capsulorhexis with anterior vitrectomy was done. Sharma et al. [23] reported the sequelae of uveitis (posterior synechia and intraocular lens deposits) in one-third of the eyes in a study that included traumatic paediatric cataract and implanted PMMA intraocular lens.

Posterior capsulorhexis during surgery provides a route of spread of inflammatory response to the anterior vitreous which enhances the proliferation of lens epithelial cells onto anterior vitreous surface and lead to opacification of visual axis [21]. Hence we left the posterior capsule intact during surgery and did aNd:YAG capsulotomy only after the eyes were quite with no cells and only minimal flare.

Nd:YAG laser posterior capsulotomy is a relatively safe technique of opening the posterior capsulewith a short, high-power pulse. The minimal amount of energy necessary to rupture the capsule is used. With most lasers, the capsule can be opened by using 1 to 2 mJ/pulse. The capsule is examined for tension lines. Shots are placed across tension lines. This results in larger opening per pulse because the tension causes the initial opening to widen.The capsulotomy is done in a cruciate pattern. Minimal amount of energy must be employed carefully so that pits and cracks are avoided on the IOL. The capsulotomy should be as large as the pupil in isotopic conditions [24].

Our results showed promising data that visual axis opacification was never encountered when posterior capsule was left intact during surgery and followed with YAG capsulotomy within two weeks’ time in children more than 3 years of age. Despite the smaller number of patients and a limited period of follow up our study provides valuable and promising information. However a longer follow up in a larger study population would be needed to further evaluate the efficacy of YAG capsulotomy over conventional posterior capsulotomy with anterior vitrectomy in pediatric age group.

Conclusion

Posterior capsulorhexis with anterior vitrectomy remains the preferred choice in younger children less than 3 years but needs greater surgical expertise. Prolonged surgical time, risk of cystoid macular edema, chances of vitreous loss through surgical wound and retinal detachment are the major drawbacks especially in the hands of inexperienced surgeons. Hence leaving the vitreous undisturbed and performing a YAG capsulotomy is proposed which is safer than a primary surgical posterior capsulorhexis with anterior vitrectomy especially in older children more than 3 years.

References

1. Sheeladevi S, Lawrenson JG, Fielder AR, Suttle CM. Global prevalence of childhood cataract: a systematic review. Eye. 2016 Sep 1; 30: 1160-1169.

2. Choi J, Kim JH, Kim SJ, Yu YS. Clinical characteristics, course and visual prognosis of partial cataracts that seem to be visually insignificant in children. J AAPOS. 2012; 16: 161-167.

3. Drummond GT, Hinz BJ. Management of monocular cataract with long-term dilation in children. Can J Ophthalmol. 1994; 29: 227-230.

4. Birch EE, Cheng C, Stager DR Jr, Weakley DR, Jr, Stager DR. Sr The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPOS. 2009; 13: 67-71.

5. Jeffrey BG, Birch EE, Stager DR, Weakley DR. Early binocular visual experience may improve binocular sensory outcomes in children after surgery for congenital unilateral cataract. Journal of American Association for Pediatric Ophthalmology and Strabismus. 2001 Aug 31; 5: 209-216.

6. Brar GS, Ram J, Pandav SS, Reddy GS, Singh U, Gupta A. Postoperative complications and visual results in uniocular pediatric traumatic cataract. Ophthalmic Surgery, Lasers and Imaging Retina. 2001 May 1; 32: 233-238.

7. Nishi O. Fibrinous membrane formation on the posterior chamber lens during the early postoperative period. Journal of Cataract & Refractive Surgery. 1988 Jan 31; 14: 73-77.

8. Ram J, Brar GS, Kaushik S, Gupta A, Gupta A. Role of posterior capsulotomy with vitrectomy and intraocular lens design and material in reducing posterior capsule opacification after pediatric cataract surgery. Journal of Cataract & Refractive Surgery. 2003 Aug 31; 29: 1579-84.

9. Kugelberg M, Zetterström C. Pediatric cataract surgery with or without anterior vitrectomy. Journal of Cataract & Refractive Surgery. 2002 Oct 31; 28: 1770-1773.

10. Hoyt CS, Nickel B. Aphakic cystoid macular edema: occurrence in infants and children after transpupillarylensectomy and anterior vitrectomy. Archives of Ophthalmology. 1982 May 1; 100: 746-749.

11. Keech RV, Tongue AC, Scott WE. Complications after surgery for congenital and infantile cataracts. American journal of ophthalmology. 1989 Aug 1; 108: 136-141.

12. Atkinson CS, Hiles DA. Treatment of secondary posterior capsular membranes with the Nd: YAG laser in a pediatric population. American journal of ophthalmology. 1994 Oct 1; 118: 496-501

13. Simons BD, Siatkowski RM, Schiffman JC, Flynn JT, Capó H, Muñoz M. Surgical technique, visual outcome, and complications of pediatric intraocular lens implantation. Journal of pediatric ophthalmology and strabismus. 1999 Mar 1; 36 :118-124.

14. Stager DR, Weakley DR, Hunter JS. Long-term rates of PCO following small incision foldable acrylic intraocular lens implantation in children. Journal of pediatric ophthalmology and strabismus. 2002 Mar 1; 39: 73-76.

15. Jensen AA, Basti S, Greenwald MJ, Mets MB. When may the posterior capsule be preserved in pediatric intraocular lens surgery? Ophthalmology. 2002 Feb 28; 109: 324-327.

16. Guo S, Wagner RS, Caputo A. Management of the anterior and posterior lens capsules and vitreous in pediatric cataract surgery. Journal of pediatric ophthalmology and strabismus. 2004 Sep 1; 41: 330-337.

17. Gimbel HV. Posterior continuous curvilinear capsulorhexis and optic capture of the intraocular lens to prevent secondary opacification in pediatric cataract surgery. Journal of Cataract & Refractive Surgery. 1997 Jan 1; 23: 652-656.

18. Hollick EJ, Spalton DJ, Ursell PG, Pande MV. Lens epithelial cell regression on the posterior capsule with different intraocular lens materials. British journal of ophthalmology. 1998 Oct 1; 82: 1182-1188.

19. Yorston D. Intraocular lens (IOL) implants in children. Community Eye Health. 2001; 14: 57.

20. Petric I, Loncar VL. Surgical technique and postoperative complications in pediatric cataract surgery: retrospective analysis of 21 cases. Croatian medical journal. 2004 Jun 1; 45: 287-91.

21. Vasavada AR, Trivedi RH. Role of optic capture in congenital cataract and intraocular lens surgery in children. Journal of Cataract & Refractive Surgery. 2000 Jun 30; 26:824-831.

22. Sharma N, Pushker N, Dada T, Vajpayee RB, Dada VK. Complications of pediatric cataract surgery and intraocular lens implantation. Journal of Cataract & Refractive Surgery. 1999 Dec 31; 25: 1585-1588.

23. Steinert RF, Puliafito CA. The Nd-YAG laser in ophthalmology: principles and clinical applications of photodisruption. WB Saunders Co; 1985

Other Articles

Article Image 1

Application of Anti-Scarring Drugs and Drug Delivery Systems in Glaucoma Surgeries

Anti-scarring Drugs And Drug Delivery systems (DDSs) that are more effective and safer than mitomycin C have been sought to improve the outcome of glaucoma filtration surgeries. Drugs that selectively inhibit wound healing, including anti-transforming growth factor-β and anti-vascular endothelial growth factor antibodies, have been investigated, although their advantages are yet to be verified in humans. In addition, novel sustained release DDSs with fewer toxic effects have been studied for application after glaucoma surgeries. Several potential biomaterials for such DDSs, including gelatin hydrogel, have been introduced.

Tetsuya Sugiyama


Article Image 1

Biorbital Lymphoma with Severe Exophthalmos

A 34-year-old man presented with binocular proptosis for half a year and sight lost for seven days. The patient had a facial lymphoma resection and postoperative chemotherapy five years ago.

Dajiang Wang¹ and Boyan Fang²*


Article Image 1

Research Progress and Human Clinical Trials of Mesenchymal Stem Cells in Ophthalmology: A Mini Review

Ocular diseases are devastating as most of them would cause irreversible visual impairment and blindness. Conceptually, cell replacement therapy with new ocular cells generated by ocular stem cells can substitute the degenerated or damaged cells in the diseased tissue. This concept has first been applied in the limbal transplantation by limbal progenitor cells. Unfortunately, patients with limbal stem cell deficiency and the endogenous progenitor cells present in human corneal endothelium as well as retina have limited regenerative power. In recent decades, other stem cell sources for ocular cell regeneration have been explored and are now feasible with the use of pluripotent stem cells, such as the embryonic stem cells (ESCs) and the induced pluripotent stem cells (iPSCs). Nevertheless, autologous transplantation would not be applicable using ESCs, whereas the variability of reprogramming methods as well as genetic instability of iPSCs has hindered their direct applications. Alternatively, human adult stem cells, such as hematopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) are found throughout the body and can be efficiently isolated from patients while maintaining the characteristics of self-renewal and multipotency. Superiorly, adult stem cells harness the potential to protect the ocular cells, where MSCs are able to modulate the microenvironments of the diseased eye for neuroprotection. This article compiled the current progress of MSCs in ocular research. Moreover, the updated clinical trials of adult stem cells in ocular diseases are summarized. In addition, potential challenges and future prospects of stem cell research in ophthalmology would also be discussed.

Tsz Kin Ng* and Jasmine Sum-Yee Yung


Article Image 1

Bilateral Extramacular Choroidal Neovascularization in Wet Age-Related Macular Degeneration

Purpose: Choroidal neovascularization is a common complication following several retinal conditions, most commonly age-related macular degeneration (AMD). We present a case of bilateral extramacular choroidal neovascularization in a patient with wet AMD.

Methods/Patients: Interventional Case Report. Clinical, radiologic, and angiographic correlation.

Results: An 89 year old Caucasian male with Age-related Macular Degeneration (AMD) developed bilateral vitreous hemorrhages and subretinal hemorrhages after which were noted bilateral extramacular choroidal neovascular membranes. The vitreous hemorrhage in the left eye cleared on its own, while vitrectomy was performed in the right eye. Bevacizumab (Avastin) was injected into both eyes. Eighteen months after initial presentation and three months after Bevacizumab, the patient was asymptomatic, both neovascular membranes were inactive, and visual acuity had improved to 20/70 OD and 20/100 OS.

Conclusions: We report the first case of aggressive bilateral extramacular choroidal neovascular membranes in a patient with wet AMD. The pathophysiology that causes AMD to target the macula and fovea in most cases, but the extramacular region in this case, has yet to be elucidated.

Natasha A Naik*, Yannis M Paulus and Darius M Moshfeghi 


Article Image 1

Intraocular Lens Power Calculation after Intracorneal Ring Segment Surgery for the Treatment of Post-LASIK Ectasia

Objective: To describe the method of Intraocular lens (IOL) power calculation in eyes after Intracorneal Ring Segment (ICRS) surgery for the treatment of post-LASIK ectasia.

Design: Retrospective observational case-series.

Participants: Three eyes of 2 patients were included in this study.

Methods: Corneal curvature in the central effective optical zone was averaged using corneal topography and k-reading (Kr) was calculated using Jarade IR method for Kr after LASIK. The calculated Kr was used in SRK-T formula for IOL calculation. Accuracy of this IOL calculation method was judged using the manifest refraction outcome after cataract surgery. All eyes were targeted for emmetropia after cataract.

Results: In our series, one eye developed cataract after ICRS surgery for the treatment of ectasia after hyperopic LASIK (+4 D) and 2 eyes developed cataract after ICRS surgery for the treatment of ectasia after myoic LASIK (-10 D). The spherical equivalent of manifest refraction after cataract surgery was within 1.25 D in all eyes.

Conclusion: Using the average corneal curvature in the central effective optical zone to calculate Kr “by Jarade IR” method was found to be accurate in calculating IOL power in ectatic eyes treated by ICRS surgery

Elias Jarade¹#, Ali Dirani¹,²#, Ali Fadlallah MD¹,², Elias Chelala², Henry Fakhoury¹, George Cherfan¹*


Article Image 1

Unilateral Choroidal Osteoma with Choroidal Neovascularization

Purpose: Choroidal osteoma is a rare tumor which features intraocular bone formation. This tumor can be complicated by choroidal neovascularization which is a cause of impaired vision in this condition. We present a case of choroidal osteoma with choroidal neovascularization as a complication.

Methods: Case report with clinical and angiographic correlation.

Results: A 16 year old female presented with a choroidal osteoma in the left eye complicated by choroidal neovascularization. The patient was treated with Bevacizumab; an intravitreal anti-Vascular Endothelial Growth Factor (Anti-VEGF). Following treatment there was improvement in vision as well as resolution of the choroidal neovascular membrane.

Conclusion: We present a case of choroidal osteoma with choroidal neovascular membranes. Subfoveal Choroidal Neovascularization (CNV) associated with choroidal osteoma may be safely treated with bevacizumab. Larger studies are required to fully evaluate the management and long-term outcomes of anti-VEGF therapy for CNV associated with choroidal osteoma.

Courtney M Crawford¹ and Okezie C Igboeli²*


Article Image 1

Retinal Hemorrhage after Infliximab Use

Infliximab is a chimeric monoclonal antibody against Tumor Necrosis Factor-α (TNF-α), initially developed for treatment of rheumatoid arthritis and inflammatory bowel disease

Es Souiri J¹, Abourazzak FE¹, Andaloussi Idrissi B² and Harzy T¹*


Article Image 1

Giant Retinal Tear Retinal Detachment Etiologies, Surgical Outcome and Incidence of Recurrent Retinal Detachment after Silicon Oil Removal

Purpose: To evaluate etiologies, management, and outcomes of patients with Giant Retinal Tears (GRT) undergoing primary surgery at tertiary referral center.

Methods: A Retrospective, consecutive case series of 94 patients with at least 3 months follow up after silicon oil removal. 57 eyes (60.6%) underwent vitrectomy, 36 eyes (38.3%) underwent combined vitrectomy with buckling and 1 eye (1.1%) underwent scleral buckling. Perfluorocarbon (PFCL) heavy liquid to flatten GRT f lap intraoperative has been used then PFCL air exchange then air silicon exchange in all eyes undergoing vitrectomy. Fellow eye was observed for retinal detachment.

Results: Idiopathic cause constitute 47 eyes (50%), 25 eyes (26.6%) are myopic and 22 eyes (23.4%) have history of trauma. 85 eyes (90.4%) achieved anatomic success. Visual acuity at the last follow-up was at least 20/400 in 71 eyes (75.5%) of patients. Recurrent retinal detachment after Silicon Oil Removal (SOR) was found in 21 eyes (22.3%) of which, 50% had Proliferative Vitreoretinopathy Grade C (PVR-C) or more (p value 0.03) and 20% had GRT size more than 180° (p value 0.04). Pars Plana Vitrectomy (PPV) alone (p value 0.89) or combined PPV with buckling (p value 0.98) have no significant correlation with recurrent Retinal Detachment (RD). 21% of the fellow eye had retinal detachment.

Conclusion: Idiopathic cause constitutes the majority 50%. Patients with GRT who underwent surgery achieved high anatomic success rate. PVR-C or more remain the most significant risk factor for recurrent RD after SOR whereas PPV alone or combined PPV with buckling have no significant correlation with recurrent RD.

 

Eman Abo Taleb


Article Image 1

Macular Hole Surgery after Treatment with Ocriplasmin for Full Thickness Idiopathic Macular Holes with Vitreomacular Traction

Purpose: To report the efficacy of Ocriplasmin in the treatment of small-medium sized idiopathic full thickness Macular Holes with focal Vitreomacular traction in comparison with vitreous surgery.

Methods: Retrospective observational single-centre small case series (n=6) studythat included patients who underwent vitrectomy after unsuccessful treatment ofsmall-medium size full thickness Idiopathic macular holes with ocriplasmin.

Results: 6 eyes with full-thickness macular holes and VMT were included, whereby in 4 eyes an epiretinal membrane was present (66.7%). Resolution of VMT after intravitreal injection of ocriplasmin was shown in three out of six eyes (50%) and in all six eyes after vitrectomy (100%). Of all six eyes presenting macular holes with a mean size of 265 µm ± 109 µm at baseline visit, five eyes showed persistent macular holes at the second follow-up visit with a mean size of 335 µm ± 166 µm. After vitrectomy no macular hole could be detected at the f inal follow-up visit.

Conclusion: We present our clinical experience with intravitreous injection of Ocriplasmin to confirm the presumed therapeutic effect in patients suffering from Vitreomacular Traction (VMT) with small-medium sizedfull thickness Macular holes (MH). Small macular holes could frequently be closed with only Ocriplasmin and without surgery with a 17% closure rate. Enlargement in all holes that failed to close with Ocriplasmin was observed in all treated eyes which makes us believe that the VMT could have a Protective role. Ellipsoid zone disruptions were evident in 50% of treated eyes and more common in eyes with successful VMT release. Although data on Ocriplasmin from several studies remain controversial but so far the results are consistent with the results and recommendations of other clinical studies and the European Medicine Agency. We agree that replacing vitrectomy for MHs with one injection of Ocriplasmin would be a very attractive option but so far Pars plana vitrectomy remain the treatment of choice for most eyes with MHs. Further Work is recommended to reveal the Cause of the ellipsoid zone Changes, the mechanisms of tractional forces and to investigate the Long term side effects of Ocriplasmin.

Khaled Helaiwa¹,², Ammar Heider², KU Bartz-Schmidt¹ and Kai Januschowski¹,²*


Article Image 1

Comparing Refractive Outcomes of Standard Phacoemulsification with Femtosecond Laser-Assisted Cataract during the Initial Learning Curve and with More Experience

Purpose: To analyze and compare the refractive outcomes of standard phacoemulsification with femtosecond laser-assisted cataract surgery performed during the initial learning curve and a year later by experienced surgeons.

Methods: This single-center retrospective study was divided into 3 groups: Group 1, 63 patients who underwent standard phacoemulsification (control group) prior to femtosecond laser acquisition by two anterior segment surgeons; Group 2, the first 104 patients who underwent femtosecond laser-assisted cataract surgery by the same surgeons from Feb 19, 2014 to April 30, 2014 (learning curve group) and Group 3,108 patients who underwent femtosecond laser-assisted cataract surgery by the same surgeons a year later from Feb, 2015 until June 30, 2015 (experienced group).

Results: Mean absolute refraction prediction errors were 0.37 ± 0.25 Diopters (D) in the control group, 0.30 ± 0.24 D in the “learning group” and 0.30 ± 0.24 D in the experienced group with no significant differences among groups. The percentages of eyes within 0.5 D of the targeted refraction were 69.8%, 90.5% and 82.5% in the control group, learning group, and experienced group, respectively (p

Conclusion: There was no statistically significant difference in the mean postoperative refraction prediction errors between femtosecond laser-assisted cataract surgery and standard phacoemulsification in either the learning curve or experienced group. However, a higher percentage of patients were within 0.5 D of the targeted refraction in the learning curve femtosecond laser-assisted cataract surgery group compared with the standard phacoemulsification group.

Ildamaris Montes de Oca, Sumitra S Khandelwal, Eric J Kim, Tim Soeken, Ryan Barrett, Li Wang, Mitchell P Weikert, Douglas D Koch and Zaina Al-Mohtaseb*